keyword
https://read.qxmd.com/read/38530090/psl-chemical-biology-symposia-recent-progress-in-ferroptosis
#1
JOURNAL ARTICLE
Arthur Pereira, Leeroy Baron, Romain Bucci, Marina Plays, Giulia Bonasegale, Armel Picard-Bernes, Manuel Bibrowski, Nolwenn Morris, Sacha Marynberg, Fabien Sindikubwabo, Tatiana Cañeque, Sebastian Müller, Ludovic Colombeau, Stéphanie Solier, Yannick Bono, Christine Gaillet, Ludger Johannes, Alain Puisieux, Raphaël Rodriguez
This symposium is the 5th PSL (Paris Sciences & Lettres) Chemical Biology meeting (2015, 2016, 2019, 2023, 2024) held at Institut Curie. This initiative originally started at Institut de Chimie des Substances Naturelles (ICSN) in Gif-sur-Yvette, with a strong focus on chemistry. It was then continued at the Institut Curie (2015) covering a larger scope, before becoming the official PSL Chemical Biology meeting. This latest edition hosted around 150 participants and was focused on the burgeoning field of ferroptosis, its mechanism and implications in health and disease...
March 26, 2024: Chembiochem: a European Journal of Chemical Biology
https://read.qxmd.com/read/38514456/eu-life-charter-of-independent-life-science-research-institutes
#2
EDITORIAL
Giulio Superti-Furga, Marta Agostinho, Jo Bury, Simon Cook, Christine Durinx, Anita Ender, Henri van Luenen, Anders H Lund, René H Medema, Marta Miączyńska, Dorthe Nickel, Pier Giuseppe Pelicci, Alain Puisieux, Samuli Ripatti, Maike Sander, Dirk Schubeler, Luis Serrano, Thomas Sommer, Katrine Sonne-Hansen, Pavel Tomančák, Joan Vives, John Vontas, Mónica Bettencourt-Dias
The diverse range of organizations contributing to the global research ecosystem is believed to enhance the overall quality and resilience of its output. Mid-sized autonomous research institutes, distinct from universities, play a crucial role in this landscape. They often lead the way in new research fields and experimental methods, including those in social and organizational domains, which are vital for driving innovation. The EU-LIFE alliance was established with the goal of fostering excellence by developing and disseminating best practices among European biomedical research institutes...
March 21, 2024: FEBS Letters
https://read.qxmd.com/read/38354248/cooperative-pro-tumorigenic-adaptation-to-oncogenic-ras-through-epithelial-to-mesenchymal-plasticity
#3
JOURNAL ARTICLE
Hadrien De Blander, Laurie Tonon, Frédérique Fauvet, Roxane M Pommier, Christelle Lamblot, Rahma Benhassoun, Francesca Angileri, Benjamin Gibert, Raphaël Rodriguez, Maria Ouzounova, Anne-Pierre Morel, Alain Puisieux
In breast cancers, aberrant activation of the RAS/MAPK pathway is strongly associated with mesenchymal features and stemness traits, suggesting an interplay between this mitogenic signaling pathway and epithelial-to-mesenchymal plasticity (EMP). By using inducible models of human mammary epithelial cells, we demonstrate herein that the oncogenic activation of RAS promotes ZEB1-dependent EMP, which is necessary for malignant transformation. Notably, EMP is triggered by the secretion of pro-inflammatory cytokines from neighboring RAS-activated senescent cells, with a prominent role for IL-6 and IL-1α...
February 16, 2024: Science Advances
https://read.qxmd.com/read/37813278/spatial-transcriptomics-reveal-pitfalls-and-opportunities-for-the-detection-of-rare-high-plasticity-breast-cancer-subtypes
#4
JOURNAL ARTICLE
Angèle Coutant, Vincent Cockenpot, Lauriane Muller, Cyril Degletagne, Roxane Pommier, Laurie Tonon, Maude Ardin, Marie-Cécile Michallet, Christophe Caux, Marie Laurent, Anne-Pierre Morel, Pierre Saintigny, Alain Puisieux, Maria Ouzounova, Pierre Martinez
Breast cancer is one of the most prominent types of cancers1 , in which therapeutic resistance is a major clinical concern. Specific subtypes like Claudin-low (CL) and metaplastic breast cancers (MpBC) have been associated with high non-genetic plasticity, which can facilitate resistance. The similarities and differences between these orthogonal subtypes, identified respectively by molecular and histopathological analyses, remain insufficiently characterized. Furthermore, adequate methods to identify high-plasticity tumors to better anticipate resistance are lacking...
October 7, 2023: Laboratory Investigation; a Journal of Technical Methods and Pathology
https://read.qxmd.com/read/37806862/-oncology-research-congress-the-essentials-of-the-fifth-international-symposium-2022-of-the-cancer-research-center-of-lyon
#5
Marie Alexandra Albaret, Eliezer Aïmontché, Nathalie Bendriss-Vermare, Jean-Jacques Diaz, Clara Gil, Jordan Hedjam, Gabriel Ichim, Chloé Morin, Nour-El-Houda Mourksi, Trang Thi Minh Nguyen, Valentin Picant, Emilie Picard, Nikolay Popgeorgiev, Franck Tirode, Hélène Vanacker, Alain Puisieux, Patrick Mehlen
No abstract text is available yet for this article.
October 6, 2023: Bulletin du Cancer
https://read.qxmd.com/read/37377900/dissecting-the-origin-of-heterogeneity-in-uterine-and-ovarian-carcinosarcomas
#6
JOURNAL ARTICLE
Anne-Sophie Sertier, Anthony Ferrari, Roxane M Pommier, Isabelle Treilleux, Sandrine Boyault, Mojgan Devouassoux-Shisheboran, Janice Kielbassa, Emilie Thomas, Laurie Tonon, Vincent Le Texier, Amandine Charreton, Anne-Pierre Morel, Anne Floquet, Florence Joly, Dominique Berton-Rigaud, Gwenaël Ferron, Laurent Arnould, Sabrina Croce, Guillaume Bataillon, Pierre Saintigny, Eliane Mery-Lamarche, Christine Sagan, Aruni P Senaratne, Ivo G Gut, Fabien Calvo, Alain Viari, Maria Ouzounova, Isabelle Ray-Coquard, Alain Puisieux
UNLABELLED: Gynecologic carcinosarcomas (CS) are biphasic neoplasms composed of carcinomatous (C) and sarcomatous (S) malignant components. Because of their rarity and histologic complexity, genetic and functional studies on CS are scarce and the mechanisms of initiation and development remain largely unknown. Whole-genome analysis of the C and S components reveals shared genomic alterations, thus emphasizing the clonal evolution of CS. Reconstructions of the evolutionary history of each tumor further reveal that C and S samples are composed of both ancestral cell populations and component-specific subclones, supporting a common origin followed by distinct evolutionary trajectories...
May 2023: Cancer Res Commun
https://read.qxmd.com/read/37100912/a-druggable-copper-signalling-pathway-that-drives-inflammation
#7
JOURNAL ARTICLE
Stéphanie Solier, Sebastian Müller, Tatiana Cañeque, Antoine Versini, Arnaud Mansart, Fabien Sindikubwabo, Leeroy Baron, Laila Emam, Pierre Gestraud, G Dan Pantoș, Vincent Gandon, Christine Gaillet, Ting-Di Wu, Florent Dingli, Damarys Loew, Sylvain Baulande, Sylvère Durand, Valentin Sencio, Cyril Robil, François Trottein, David Péricat, Emmanuelle Näser, Céline Cougoule, Etienne Meunier, Anne-Laure Bègue, Hélène Salmon, Nicolas Manel, Alain Puisieux, Sarah Watson, Mark A Dawson, Nicolas Servant, Guido Kroemer, Djillali Annane, Raphaël Rodriguez
Inflammation is a complex physiological process triggered in response to harmful stimuli1 . It involves cells of the immune system capable of clearing sources of injury and damaged tissues. Excessive inflammation can occur as a result of infection and is a hallmark of several diseases2-4 . The molecular bases underlying inflammatory responses are not fully understood. Here we show that the cell surface glycoprotein CD44, which marks the acquisition of distinct cell phenotypes in the context of development, immunity and cancer progression, mediates the uptake of metals including copper...
April 26, 2023: Nature
https://read.qxmd.com/read/36942862/psl-chemical-biology-symposia-third-edition-a-branch-of-science-in-its-explosive-phase
#8
JOURNAL ARTICLE
Leeroy Baron, Justine Hadjerci, Leishemba Thoidingjam, Marina Plays, Romain Bucci, Nolwenn Morris, Sebastian Müller, Fabien Sindikubwabo, Stéphanie Solier, Tatiana Cañeque, Ludovic Colombeau, Cedric M Blouin, Christophe Lamaze, Alain Puisieux, Yannick Bono, Christine Gaillet, Luca Laraia, Boris Vauzeilles, Frédéric Taran, Sébastien Papot, Philippe Karoyan, Romain Duval, Florence Mahuteau-Betzer, Paola Arimondo, Kevin Cariou, Gilles Guichard, Laurent Micouin, Mélanie Ethève-Quelquejeu, Daniela Verga, Antoine Versini, Gilles Gasser, Cong Tang, Philippe Belmont, Andreas Linkermann, Claudia Bonfio, Dennis Gillingham, Thomas Poulsen, Marco Di Antonio, Marie Lopez, Dominique Guianvarc'h, Christophe Thomas, Géraldine Masson, Arnaud Gautier, Ludger Johannes, Raphaël Rodriguez
This symposium is the third PSL (Paris Sciences & Lettres) Chemical Biology meeting (2016, 2019, 2023) held at Institut Curie. This initiative originally started at Institut de Chimie des Substances Naturelles (ICSN) in Gif-sur-Yvette (2013, 2014), under the directorship of Professor Max Malacria, with a strong focus on chemistry. It was then continued at the Institut Curie (2015) covering a larger scope, before becoming the official PSL Chemical Biology meeting. This latest edition was postponed twice for the reasons that we know...
March 21, 2023: Chembiochem: a European Journal of Chemical Biology
https://read.qxmd.com/read/36765930/intestinal-epithelial-cells-adapt-to-chronic-inflammation-through-partial-genetic-reprogramming
#9
JOURNAL ARTICLE
Guillaume Collin, Jean-Philippe Foy, Nicolas Aznar, Nicolas Rama, Anne Wierinckx, Pierre Saintigny, Alain Puisieux, Stéphane Ansieau
Reactive oxygen species (ROS) are considered to be the main drivers of inflammatory bowel disease. We investigated whether this permanent insult compels intestinal stem cells to develop strategies to dampen the deleterious effects of ROS. As an adverse effect, this adaptation process may increase their tolerance to oncogenic insults and facilitate their neoplastic transformation. We submitted immortalized human colonic epithelial cells to either a mimic of chronic inflammation or to a chemical peroxide, analyzed how they adapted to stress, and addressed the biological relevance of these observations in databases...
February 3, 2023: Cancers
https://read.qxmd.com/read/36257549/serum-neutralization-of-sars-cov-2-omicron-sublineages-ba-1-and-ba-2-and-cellular-immune-responses-3-months-after-booster-vaccination
#10
JOURNAL ARTICLE
Enagnon Kazali Alidjinou, Julie Demaret, Bénédicte Corroyer-Simovic, Fanny Vuotto, Sophie Miczek, Julien Labreuche, Anne Goffard, Jacques Trauet, Daniela Lupau, Arnaud Dendooven, Dominique Huvent-Grelle, Juliette Podvin, Daniel Dreuil, Karine Faure, Dominique Deplanque, Laurence Bocket, Alain Duhamel, Annie Sobaszek, Didier Hober, Michael Hisbergues, Francois Puisieux, Brigitte Autran, Yazdan Yazdanpanah, Myriam Labalette, Guillaume Lefèvre
OBJECTIVES: We investigated serum neutralizing activity against BA.1 and BA.2 Omicron sublineages, and T cell response before and 3 months after booster vaccine in healthcare workers (HCWs). METHODS: HCWs aged 18-65 years, vaccinated and boosted with the BNT162b2 vaccine were included. Anti-SARS-CoV-2 IgG levels and cellular response (through IFNγ ELISpot assay) were evaluated in all participants, and neutralizing antibodies against Delta, BA.1 and BA.2 were evaluated in participants with at least one follow-up visit 1 or 3 months after the booster dose...
October 15, 2022: Clinical Microbiology and Infection
https://read.qxmd.com/read/35696539/iron-sensitive-prodrugs-that-trigger-active-ferroptosis-in-drug-tolerant-pancreatic-cancer-cells
#11
JOURNAL ARTICLE
Michał Antoszczak, Sebastian Müller, Tatiana Cañeque, Ludovic Colombeau, Nelson Dusetti, Patricia Santofimia-Castaño, Christine Gaillet, Alain Puisieux, Juan Lucio Iovanna, Raphaël Rodriguez
Persister cancer cells represent rare populations of cells resistant to therapy. Cancer cells can exploit epithelial-mesenchymal plasticity to adopt a drug-tolerant state that does not depend on genetic alterations. Small molecules that can interfere with cell plasticity or kill cells in a cell state-dependent manner are highly sought after. Salinomycin has been shown to kill cancer cells in the mesenchymal state by sequestering iron in lysosomes, taking advantage of the iron addiction of this cell state. Here, we report the chemo- and stereoselective synthesis of a series of structurally complex small molecule chimeras of salinomycin derivatives and the iron-reactive dihydroartemisinin...
July 6, 2022: Journal of the American Chemical Society
https://read.qxmd.com/read/35550950/epithelial-to-mesenchymal-transition-promotes-immune-escape-by-inducing-cd70-in-non-small-cell-lung-cancer
#12
JOURNAL ARTICLE
Sandra Ortiz-Cuaran, Aurélie Swalduz, Jean-Philippe Foy, Solène Marteau, Anne-Pierre Morel, Frédérique Fauvet, Geneviève De Souza, Lucas Michon, Maxime Boussageon, Nicolas Gadot, Marion Godefroy, Sophie Léon, Antonin Tortereau, Nour-El-Houda Mourksi, Camille Leonce, Marie Alexandra Albaret, Anushka Dongre, Béatrice Vanbervliet, Marie Robert, Laurie Tonon, Roxane M Pommier, Véronique Hofman, Valéry Attignon, Sandrine Boyault, Carole Audoynaud, Jessie Auclair, Fanny Bouquet, Qing Wang, Christine Ménétrier-Caux, Maurice Pérol, Christophe Caux, Paul Hofman, Sylvie Lantuejoul, Alain Puisieux, Pierre Saintigny
INTRODUCTION: Epithelial-to-mesenchymal transition (EMT) is associated with tumor aggressiveness, drug resistance, and poor survival in non-small cell lung cancer (NSCLC) and other cancers. The identification of immune-checkpoint ligands (ICPLs) associated with NSCLCs that display a mesenchymal phenotype (mNSCLC) could help to define subgroups of patients who may benefit from treatment strategies using immunotherapy. METHODS: We evaluated ICPL expression in silico in 130 NSCLC cell lines...
July 2022: European Journal of Cancer
https://read.qxmd.com/read/35545761/low-level-of-fibrillarin-a-ribosome-biogenesis-factor-is-a-new-independent-marker-of-poor-outcome-in-breast-cancer
#13
JOURNAL ARTICLE
Flora Nguyen Van Long, Audrey Lardy-Cleaud, Dimitri Carène, Caroline Rossoni, Frédéric Catez, Paul Rollet, Nathalie Pion, Déborah Monchiet, Agathe Dolbeau, Marjorie Martin, Valentin Simioni, Susan Bray, Doris Le Beherec, Fernanda Mosele, Ibrahim Bouakka, Amélie Colombe-Vermorel, Laetitia Odeyer, Alexandra Diot, Lee B Jordan, Alastair M Thompson, Françoise Jamen, Thierry Dubois, Sylvie Chabaud, Stefan Michiels, Isabelle Treilleux, Jean-Christophe Bourdon, David Pérol, Alain Puisieux, Fabrice André, Jean-Jacques Diaz, Virginie Marcel
BACKGROUND: A current critical need remains in the identification of prognostic and predictive markers in early breast cancer. It appears that a distinctive trait of cancer cells is their addiction to hyperactivation of ribosome biogenesis. Thus, ribosome biogenesis might be an innovative source of biomarkers that remains to be evaluated. METHODS: Here, fibrillarin (FBL) was used as a surrogate marker of ribosome biogenesis due to its essential role in the early steps of ribosome biogenesis and its association with poor prognosis in breast cancer when overexpressed...
May 11, 2022: BMC Cancer
https://read.qxmd.com/read/35534984/role-of-emt-in-the-dna-damage-response-double-strand-break-repair-pathway-choice-and-its-implications-in-cancer-treatment
#14
REVIEW
Caroline Moyret-Lalle, Mélanie K Prodhomme, Delphine Burlet, Ayaka Kashiwagi, Virginie Petrilli, Alain Puisieux, Hiroyuki Seimiya, Agnès Tissier
Numerous epithelial-mesenchymal transition (EMT) characteristics have now been demonstrated to participate in tumor development. Indeed, EMT is involved in invasion, acquisition of stem cell properties and therapy-associated resistance of cancer cells. Together, these mechanisms offer advantages in adapting to changes in the tumor microenvironment. However, recent findings have shown that the EMT-associated transcription factors (EMT-TFs) may also be involved in DNA repair. A better understanding of the coordination between the DNA repair pathways and the role played by some EMT-TFs in the DNA damage response (DDR) should pave the way for new treatments targeting tumor-specific molecular vulnerabilities, which results in selective destruction of cancer cells...
May 9, 2022: Cancer Science
https://read.qxmd.com/read/35469147/immunogenicity-of-bnt162b2-vaccine-booster-against-sars-cov-2-delta-and-omicron-variants-in-nursing-home-residents-a-prospective-observational-study-in-older-adults-aged-from-68-to-98-years
#15
JOURNAL ARTICLE
Enagnon Kazali Alidjinou, Julie Demaret, Bénédicte Corroyer-Simovic, Julien Labreuche, Anne Goffard, Jacques Trauet, Daniela Lupau, Sophie Miczek, Fanny Vuotto, Arnaud Dendooven, Dominique Huvent-Grelle, Juliette Podvin, Daniel Dreuil, Karine Faure, Dominique Deplanque, Laurence Bocket, Alain Duhamel, Annie Sobaszek, Didier Hober, Michael Hisbergues, Francois Puisieux, Brigitte Autran, Yazdan Yazdanpanah, Myriam Labalette, Guillaume Lefèvre
Background: The present study aimed to evaluate the persistent immunogenicity offered by a third dose of BNT162b2 against Delta and Omicron variants, in nursing home (NH) residents. Methods: In this monocenter prospective observational study, anti-spike IgG levels, S1 domain reactive T cell counts, serum neutralizing antibody titers against Delta and Omicron variants were compared before and up to three months after the BNT162b2 booster dose, in NH residents without COVID-19 (COVID-19 naive) or with COVID-19 prior to initial vaccination (COVID-19 recovered)...
June 2022: The Lancet regional health. Europe
https://read.qxmd.com/read/34868051/impaired-functional-t-cell-response-to-sars-cov-2-after-two-doses-of-bnt162b2-mrna-vaccine-in-older-people
#16
JOURNAL ARTICLE
Julie Demaret, Bénédicte Corroyer-Simovic, Enagnon Kazali Alidjinou, Anne Goffard, Jacques Trauet, Sophie Miczek, Fanny Vuotto, Arnaud Dendooven, Dominique Huvent-Grelle, Juliette Podvin, Daniel Dreuil, Karine Faure, Dominique Deplanque, Laurence Bocket, Alain Duhamel, Julien Labreuche, Annie Sobaszek, Michael Hisbergues, Francois Puisieux, Myriam Labalette, Guillaume Lefèvre
Long-term care facility (LTCF) older residents display physiological alterations of cellular and humoral immunity that affect vaccine responses. Preliminary reports suggested a low early postvaccination antibody response against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The aim of this study was to focus on the specific T-cell response. We quantified S1-specific IgG, neutralizing antibody titers, total specific IFNγ-secreting T cells by ELISpot, and functionality of CD4+ - and CD8+ -specific T cells by flow cytometry, after two doses of the BNT162b2 vaccine in younger and older people, with and without previous COVID-19 infection (hereafter referred to as COVID-19-recovered and COVID-19-naive subjects, respectively)...
2021: Frontiers in Immunology
https://read.qxmd.com/read/34654908/author-correction-guidelines-and-definitions-for-research-on-epithelial-mesenchymal-transition
#17
Jing Yang, Parker Antin, Geert Berx, Cédric Blanpain, Thomas Brabletz, Marianne Bronner, Kyra Campbell, Amparo Cano, Jordi Casanova, Gerhard Christofori, Shoukat Dedhar, Rik Derynck, Heide L Ford, Jonas Fuxe, Antonio García de Herreros, Gregory J Goodall, Anna-Katerina Hadjantonakis, Ruby Y J Huang, Chaya Kalcheim, Raghu Kalluri, Yibin Kang, Yeesim Khew-Goodall, Herbert Levine, Jinsong Liu, Gregory D Longmore, Sendurai A Mani, Joan Massagué, Roberto Mayor, David McClay, Keith E Mostov, Donald F Newgreen, M Angela Nieto, Alain Puisieux, Raymond Runyan, Pierre Savagner, Ben Stanger, Marc P Stemmler, Yoshiko Takahashi, Masatoshi Takeichi, Eric Theveneau, Jean Paul Thiery, Erik W Thompson, Robert A Weinberg, Elizabeth D Williams, Jianhua Xing, Binhua P Zhou, Guojun Sheng
No abstract text is available yet for this article.
December 2021: Nature Reviews. Molecular Cell Biology
https://read.qxmd.com/read/34572787/cellular-plasticity-a-route-to-senescence-exit-and-tumorigenesis
#18
REVIEW
Hadrien De Blander, Anne-Pierre Morel, Aruni P Senaratne, Maria Ouzounova, Alain Puisieux
Senescence is a dynamic, multistep program that results in permanent cell cycle arrest and is triggered by developmental or environmental, oncogenic or therapy-induced stress signals. Senescence is considered as a tumor suppressor mechanism that prevents the risk of neoplastic transformation by restricting the proliferation of damaged cells. Cells undergoing senescence sustain important morphological changes, chromatin remodeling and metabolic reprogramming, and secrete pro-inflammatory factors termed senescence-associated secretory phenotype (SASP)...
September 11, 2021: Cancers
https://read.qxmd.com/read/34458275/opposite-roles-for-zeb1-and-tmej-in-the-regulation-of-breast-cancer-genome-stability
#19
REVIEW
Mélanie K Prodhomme, Sarah Péricart, Roxane M Pommier, Anne-Pierre Morel, Anne-Cécile Brunac, Camille Franchet, Caroline Moyret-Lalle, Pierre Brousset, Alain Puisieux, Jean-Sébastien Hoffmann, Agnès Tissier
Breast cancer cells frequently acquire mutations in faithful DNA repair genes, as exemplified by BRCA-deficiency. Moreover, overexpression of an inaccurate DNA repair pathway may also be at the origin of the genetic instability arising during the course of cancer progression. The specific gain in expression of POLQ , encoding the error-prone DNA polymerase Theta (POLθ) involved in theta-mediated end joining (TMEJ), is associated with a characteristic mutational signature. To gain insight into the mechanistic regulation of POLQ expression, this review briefly presents recent findings on the regulation of POLQ in the claudin-low breast tumor subtype, specifically expressing transcription factors involved in epithelial-to-mesenchymal transition (EMT) such as ZEB1 and displaying a paucity in genomic abnormality...
2021: Frontiers in Cell and Developmental Biology
https://read.qxmd.com/read/34319295/erratum-ribosomal-rna-2-o-methylation-as-a-novel-layer-of-inter-tumour-heterogeneity-in-breast-cancer
#20
Virginie Marcel, Janice Kielbassa, Virginie Marchand, Kundhavai S Natchiar, Hermes Paraqindes, Flora Nguyen Van Long, Lilia Ayadi, Valérie Bourguignon-Igel, Piero Lo Monaco, Déborah Monchiet, Véronique Scott, Laurie Tonon, Susan E Bray, Alexandra Diot, Lee B Jordan, Alastair M Thompson, Jean-Christophe Bourdon, Thierry Dubois, Fabrice André, Frédéric Catez, Alain Puisieux, Yuri Motorin, Bruno P Klaholz, Alain Viari, Jean-Jacques Diaz
[This corrects the article DOI: 10.1093/narcan/zcaa036.].
March 2021: NAR cancer
keyword
keyword
13505
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.